This week Mike Rea is asking about the purpose of research and how it should be directed to deliver truly great insight that is of real value.
It has been said that the definition of madness is to keep doing the same thing again and expect a different outcome. This doesn’t seem to apply to market research…
Read the full article
pharmaphorum invites feedback from our readers on the recent interview marcus evans conducted with Malcolm Weir, CEO of Heptares Therapeutics, discussing the challenges of drug discovery today.
Statistics seem almost stacked against developing a fitting drug for a target disease. Drug discovery is plagued by time consuming and costly…
Read the full article
As joint working and cooperation move to replace push selling by pharma, Alan Naismith draws a tongue in cheek comparison with crumbling bridges and challenges the industry to engage more quickly in such initiatives.
After the devastating floods in Cumbria in November an analogy about bridges may seem a little tasteless, but it is very apt. The bridge I refer to is the one formed by…
Read the full article
Dr. Paul Stuart-Kregor discusses the topic of joint working in the UK and takes a look at some of the challenges the commercial industry must overcome to embrace it.
Much has been made of the changing nature of pharma’s customer base. No longer is the GP king or queen in the UK. Rather their medical practice is…
Read the full article
As the world of social media continues to explode in 2010, Dr. Andree Bates takes a look at why it has yet to make a major impact in pharma and what to do about it.
Every man and his dog is talking about social media right now. Social media is the biggest revolution to have happened…
Read the full article